The Role of Placental Exosomes in Reproduction

American Journal of Reproductive Immunology

Volumn 63, Issue 6, 2010, Pages 520-533

  Mincheva Nilsson, Lucia ^a   Baranov, Vladimir ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Exosomes; FasL; MICA B; Microvesicles; Placenta; ULBP

Indexed keywords

ACTIN; BINDING PROTEIN; CD47 ANTIGEN; CD63 ANTIGEN; COFILIN 1; EPIDERMAL GROWTH FACTOR; ESCRT PROTEIN; FAS LIGAND; FASL 1; FASL 2; FASL 3; FASL 4; INTEGRIN; MEMBRANE PROTEIN; MESSENGER RNA; MICRORNA; MULTIPROTEIN COMPLEX; NATURAL KILLER CELL RECEPTOR NKG2D; PROFILIN; PROTEIN TSAP6; PROTEIN ULBP 3; PROTEIN ULBP 4; PROTEIN ULBP 5; PROTEIN ULBP2; PROTEIN ULPB1; RAB PROTEIN; RAS PROTEIN; TRANSFERRIN RECEPTOR; TUBULIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

AMNION FLUID; BIOGENESIS; CELL COMMUNICATION; CELL INTERACTION; CELL SECRETION; CELL STRUCTURE; CYTOPLASM VESICLE; DENDRITIC CELL; EXOSOME; FLUORESCENCE ACTIVATED CELL SORTING; GENE IDENTIFICATION; HUMAN; IMMUNE RESPONSE; PHENOTYPE; PLACENTA; PLACENTA FUNCTION; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TROPHOBLAST; ANIMAL; FEMALE; IMMUNOLOGY; METABOLISM; MOUSE; SECRETION (PROCESS); ULTRASTRUCTURE;

ANIMALS; CELL COMMUNICATION; EXOSOMES; FEMALE; HUMANS; MICE; PLACENTA; PREGNANCY; SIGNAL TRANSDUCTION;

EID: 77953922692     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00822.x     Document Type: Review

References (74)

1. Abrahams VM, Straszewski-Chavez SL, Guller S, Mor G. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod 2004, 10:55-63.
2. Frängsmyr L, Baranov V, Nagaeva O, Stendahl U, Kjellberg L, Mincheva-Nilsson L. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol Hum Reprod 2005, 11:35-41.
3. Taylor DD, Akyol S, Gercel-Taylor C. Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol 2006, 176:1534-1542.
4. Sabapatha A, Gercel-Taylor C, Taylor DD. Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol 2006, 56:345-355.
5. Mincheva-Nilsson L, Nagaeva O, Chen T, Stendahl U, Antsiferova J, Mogren I, Hernestål J, Baranov V. Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival. J Immunol 2006, 176:3585-3592.
6. Hedlund M, Stenqvist A-C, Nagaeva O, Kjellberg L, Wulff M, Baranov V, Mincheva-Nilsson L. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J Immunol 2009, 183:340-351.
7. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, Ratajczak MZ. Embryonic stem cell-derived microvesicles reprogram hematopoietic projenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006, 20:847-856.
8. Rechavi O, Goldstein I, Kloog Y. Intercellular exchange of proteins: the immune cell habit of sharing. FEBS Lett 2009, 583:1792-1799.
9. Johnstone RM. Revisiting the road to the discovery of exosomes. Blood Cells Mol Dis 2005, 34:214-219.
10. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2:569-579.
11. Keller S, Sanderson MP, Stoek A, Altevogt P. Exosomes: from biogenesis to biological function. Immunol Lett 2006, 107:102-108.
12. Culler S. Role of the syncytium in placenta-mediated complications of preeclampsia. Thromb Res 2009, 123:389-392.
13. Tooth B, Lok CAR, Böing A, Diamant M, van der Post JAM, Friese K, Nieuwland R. Microparticles and exosomes: impact on normal and complicated pregnancy. Am J Reprod Immunol 2007, 58:389-402.
14. Redman CWG, Sargent IL. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J Reprod Immunol 2007, 76:61-67.
15. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-cell communication. Leukemia 2006, 20:1487-1495.
16. Morel O, Toti F, Hugel B, Freyssinet JM. Cellular microparticles; a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004, 11:156-164.
17. Beaudoin AR, Grondin G. Shedding of vesicular material from the cell surface of eukaryotic cells: different cellular phenomena. Biochim Biophys Acta 1991, 1071:203-219.
18. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19:43-51.
19. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009, 9:581-593.
20. Delves GH, Stewart AB, Cooper AJ, Lwaleed BA. Prostasomes, angiogenesis, and tissue factor. Semin Thromb Hemost 2007, 33:75-79.
21. Marzesco A-M, Janich P, Wilsch-Brauninger M, Dubreuil V, Langenfeld K, Corbeil D, Huttner WB. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci 2005, 118:2849-2858.
22. Lakkaraju A, Rodriguez-Boulan E. Itinerant exosomes:emerging roles in cell and tissue polarity. Trends Cell Biol 2008, 18:199-209.
23. Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW, Radder JK. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002, 106:2442-2447.
24. Willekens FL, Were JM, Roerdinkholder-Stoelwinder B, Groenen-Döpp YA, van den Bos AG, Bosman GJ, van Berkel TJ. Liver Kuppfer cells rapidly remove red blood cell derived vesicles from the circulation by scavenger receptors. Blood 2005, 105:2141-2145.
25. Taylor DD, Homesley HD, Doeligast GJ. Binding specific peroxidase-labeled antibody to placental-type phosphatise on tumor-derived membrane fragments. Cancer Res 1980, 40:4064-4069.
26. Trams EG, Lauter CJ, Salem N, Heine U. Exfoliation of membrane ecto-enzymes in form of microvesicles. Biochim Biophys Acta 1981, 645:63-70.
27. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 1987, 262:9412-9420.
28. Babst M. A protein's final ESCRT. Traffic 2005, 6:2-9.
29. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brügger B, Simons M. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008, 319:1244-1247.
30. Babst M. A close-up of the ESCRTs. Dev Cell 2006, 10:547-548.
31. Hurley JH. ESCRT complexes and the biogenesis of multivesicular bodies. Curr Opin Cell Biol 2008, 20:4-11.
32. Williams RL, Urbé S. The emerging shape of the ESCRT machinery. Nat Rev Mol Cell Biol 2007, 8:355-368.
33. Amzallag N, Passer BJ, Allanic D, Segura E, Thery C, Goud B, Amson R, Telerman A. TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a non-classical pathway. J Biol Chem 2004, 279:46104-46112.
34. Savina A, Fader CM, Vidal M, Damiani MT, Colombo MI. Rab 11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic 2005, 6:131-143.
35. Simpson RJ, Jensen SS, Lim JWE. Proteomic profiling of exosomes: current perspectives. Proteomics 2008, 8:4083-4099.
36. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. Identification of Tim4 as a phospatidylserine receptor. Nature 2007, 450:435-439.
37. Simpson RG, Lim GWE, Moritz RL, Mathivanan S. Exosomes: proteomic insides and diagnostic potential. Expert Rev Proteomics 2009, 6:267-283.
38. Denzer K, Kleijmeer MJ, Heijnen HFG, Stoorvogel W, Geuze HJ. Exosome: from internal vesicle of the multivesicular body to intercellular signalling device. J Cell Sci 2000, 113:3365-3374.
39. Valadi H, Ekstöm K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
40. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT, Carter BS, Krichevsky AM, Breakfield XO. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10:1470-1476.
41. Martinez-Lorenzo MJ, Anel A, Gamen S, Monleon I, Lasierra P, Larrad L, Pineiro A, Alava MA, Naval J. Activated human T cells release bioactive Fas Ligand and APO2 ligand in microvesicles. J Immunol 1999, 163:1274-1281.
42. Mincheva-Nilsson L, Nagaeva O, Sundqvist KG, Hammarström ML, Hammarström S, Baranov V. γδT cells of human early pregnancy decidua: evidence for cytotoxic potency. Int Immunol 2000, 12:585-596.
43. Karlsson M, Lundin S, Dahlgren O, Kahu H, Petersson I, Telemo E. " Tolerosomes" are produced by intestinal epithelial cells. Eur J Immunol 2001, 31:2892-2900.
44. Clayton A, Mitchel JP, Court J, Mason MD, Tabi Z. Human tumor derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res 2007, 67:7458-7466.
45. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007, 67:2912-2915.
46. Iero M, Valenti R, Huber V, Fillipazzi P, Parmiani G, Fais S, Rivoltini L. Tumor-released exosomes and their implications in cancer immunity. Cell Death Differ 2008, 15:80-88.
47. Eblen AC, Gercel-Taylor C, Makajima ST, Taylor DD. Modulation of T cell CD3-zeta chain expression in early pregnancy. Am J Reprod Immunol 2002, 47:167-173.
48. Gercel-Taylor C, O'Connor SM, Lam GK, Taylor DD. Shed membrane fragment modulation of CD3-zeta during pregnancy: link with induction of apoptosis. J Reprod Immunol 2002, 56:29-44.
49. Eagle RA, Jafferji I, Barrow AD. Beyond stressed self: evidence for NKG2D ligand expression on healthy cells. Curr Immunol Rev 2009, 5:22-34.
50. Agüera-Gonzalez S, Boutet P, Reyburn HT, Valez-Gomez M. Brief residence at the plasma membrane of the MHC class 1-related chain B is due to clathrin-mediated cholesterol-dependent endocytosis and shedding. J Immunol 2009, 182:4800-4808.
51. Cerwenka A. New twist on the regulation of NKG2D ligand expression. J Exp Med 2009, 206:265-268.
52. Zuccato E, Blott EJ, Holt O, Sigismund S, Shaw M, Bossi G, Griffiths GM. Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation. J Cell Sci 2007, 120:191-199.
53. Eleme K, Taner ST, Önfelt B, Collinson LM, McCann FE, Chalupny NJ, Cosman D, Hopkins C, Magee AI, Davis DM. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. J Exp Med 2004, 199:1005-1010.
54. Ashiru O, Boutet P, Fernandez-Messina L, Aguiera-Gonzales S, Skepper JN, Vales-Gomez M, Reyburn HT. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res 2010, 70:481-489.
55. de Gassart A, Geminard C, Fevrier B, Raposo G, Vidal M. Lipid raft-associated protein sorting in exosomes. Blood 2003, 102:4336-4344.
56. Shudo K, Kinoshita K, Immamura R, Fan H, Hasumoto K, Tanaka M, Nagata S, Suda T. The membrane-bound but not the soluble form of human Fas ligand is responsible for its inflammatory activity. Eur J Immunol 2001, 31:2504-2511.
57. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006, Chapter 3.22.1-3.22.29
58. Mathias RA, Lim JW, Ji H, Simpson RJ. Isolation of extracellular membranous vesicles for proteomic analysis. Methods Mol Biol 2009, 528:227-242.
59. Clayton A, Court J, Navabi H, Adams M, Mason MD, Hobot JA, Newman GR, Jasani B. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods 2001, 247:163-174.
60. Taylor DD, Gercel-Taylor C, Parker LP. Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol Oncol 2009, 115:112-120.
61. Chen C, Skog J, Hsu CH, Lessard RT, Balaj L, Wurdinger T, Carter BS, Breakefield XO, Toner M, Irmia D. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab chip 2009, 10.1039/b916199f, DOI
62. Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and trombosis. Scand J Immunol 2007, 66:159-165.
63. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007, 179:5949-5956.
64. Pap E, Pallinger E, Falus A, Kiss AA, Kittel A, Kovac P, Buzas EI. T lymphocytes are targets for platelet- and trophoblast-derived microvesicles during pregnancy. Placenta 2008, 29:826-832.
65. Gupta AK, Rusterholts C, Huppertz B, Malek A, Shneider H, Holzgreve W, Hahn S. A comparative study of the effect of three different syncytiotrophoblast micro-particles on endothelial cells. Placenta 2004, 26:59-66.
66. Messerli M, May K, Hansson SR, Schneider H, Holzgreve W, Hahn S, Rusterholz C. Feto-maternal interactions in pregnancies: placental microparticles activate peripheral monocytes. Placenta 2010, 31:106-112.
67. Pap E, Pallinger E, Pasztoi M, Falus A. Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res 2009, 58:1-8.
68. Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakfield XO, Widmark A. Prostate cancer derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer 2009, 100:1603-1607.
69. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers for ovarian cancer. Gynecol Oncol 2008, 110:13-21.
70. Luo SS, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T, Takizawa I, Shigihara T, Goto T, Izumi A, Ohkuchi A, Matsubara S, Takeshita T, Takizawa T. Human villous trophoblast express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod 2009, 81:717-729.
71. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW, Lo YM. Detection and characterization of placental micro RNAs in maternal plasma. Clin Chem 2008, 54:482-490.
72. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic analysis of exosomes in human urine. Proc Natl Acad Sci USA 2004, 101:13368-13373.
73. Asea A, Claudel JP, Laur P, Rao P, Linhares IM, Skupski S, Witkin SS. Heat shock protein-containing exosomes in mid trimester amniotic fluids. J Reprod Immunol 2008, 79:12-17.
74. Keller S, Rupp C, Stoek A, Runz S, Fogel M, Lugert S, Hager H-D, Abdel-Bakky MS, Gutwein P, Altevogt P. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int 2007, 72:1095-1102.